Cite
In-vitro metabolism of LXY18, an orally available, potent blocker of AURKB relocation in mitosis.
MLA
Li, Jinhua, et al. “In-Vitro Metabolism of LXY18, an Orally Available, Potent Blocker of AURKB Relocation in Mitosis.” Journal of Pharmaceutical & Biomedical Analysis, vol. 232, Aug. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.jpba.2023.115415.
APA
Li, J., Choudhry, N., Lv, G., Nimishetti, N., Reddy, M. C., Liu, H., Allen, T. D., Zhang, J., & Yang, D. (2023). In-vitro metabolism of LXY18, an orally available, potent blocker of AURKB relocation in mitosis. Journal of Pharmaceutical & Biomedical Analysis, 232, N.PAG. https://doi.org/10.1016/j.jpba.2023.115415
Chicago
Li, Jinhua, Namrta Choudhry, Gang Lv, Naganna Nimishetti, Mallu Chenna Reddy, Hong Liu, Thaddeus D. Allen, Jing Zhang, and Dun Yang. 2023. “In-Vitro Metabolism of LXY18, an Orally Available, Potent Blocker of AURKB Relocation in Mitosis.” Journal of Pharmaceutical & Biomedical Analysis 232 (August): N.PAG. doi:10.1016/j.jpba.2023.115415.